<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00396682</url>
  </required_header>
  <id_info>
    <org_study_id>HAN-HCC-002</org_study_id>
    <secondary_id>DFG - KFO 119</secondary_id>
    <nct_id>NCT00396682</nct_id>
  </id_info>
  <brief_title>Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma</brief_title>
  <official_title>Elimination of CD4+CD25+ Regulatory T Cells in Patients With Advanced HCC After Treatment With Cyclophosphamide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hannover Medical School</source>
  <brief_summary>
    <textblock>
      It has been shown that patients with advanced HCC have an increased frequency of CD4+CD25+
      regulatory T cells. These cells might suppress tumor-specific immune responses.
      Cyclophosphamide has been shown to reduce the frequency of CD4+CD25+ regulatory T cells. The
      aim of this study is to test if the treatment with cyclophosphamide leads to a decrease in
      the frequency of CD4+CD25+ regulatory T cells and to increase tumor specific immune responses
      in patients with advanced HCC.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of CD4+CD25+regulatory T cells</measure>
    <time_frame>within 8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Tumor specific immune responses</measure>
    <time_frame>within 12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
    <time_frame>within 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function and Phenotype of CD4+CD25+ regulatory T cells</measure>
    <time_frame>within 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor response</measure>
    <time_frame>within 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Advanced HCC</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyclophosphamide</intervention_name>
    <description>150 - 250 - 350 mg</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adequate WBC

          -  adequate liver and kidney function

          -  no immunodeficiency

          -  ECOG &lt; 2

        Exclusion Criteria:

          -  advanced liver cirrhosis

          -  severe cardiopulmonary diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim F Greten, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Gastroenterology, Medizinische Hochschule Hannover</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tim F Greten, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30655</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2006</study_first_submitted>
  <study_first_submitted_qc>November 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2006</study_first_posted>
  <last_update_submitted>February 3, 2009</last_update_submitted>
  <last_update_submitted_qc>February 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Tim Greten</name_title>
    <organization>Med. Hochschule Hannover</organization>
  </responsible_party>
  <keyword>HCC</keyword>
  <keyword>T cell</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclophosphamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

